Evidence map›Paper›PMID 20832849›Full record

Trial reportThe Journal of allergy and clinical immunology2010

Mechanisms of tolerance to parental parathyroid tissue when combined with human allogeneic thymus transplantation.

Ivan K Chinn, John A Olson, Michael A Skinner, Elizabeth A McCarthy, Stephanie E Gupton, Dong-Feng Chen, Francisco A Bonilla, Robert L Roberts, Maria G Kanariou, Blythe H Devlin and 1 more

7 registry-linked trialsOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00566488 phase1completednot on this map

Parathyroid and Thymus Transplantation in DiGeorge Syndrome, #931

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2005 to 2019Enrolled25ConditionsDiGeorge Syndrome, Hypoparathyroidism, Complete DiGeorge SyndromeArmsThymus/Parathyroid Transplantation
NCT00576407 phase2completednot on this map

Phase II Study of Thymus Transplantation in Complete DiGeorge Syndrome #668

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan1991 to 2017Enrolled26ConditionsDiGeorge Syndrome, Complete Typical DiGeorge AnomalyArmsCultured Thymus Tissue for Implantation (CTTI)
NCT00576836 phase2completednot on this map

Dose Study of Thymus Transplantation in DiGeorge Anomaly, IND 9836, #932.1

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2004 to 2019Enrolled7ConditionsDiGeorge Anomaly, DiGeorge Syndrome, Complete DiGeorge Anomaly, Complete DiGeorge SyndromeArmsCultured Thymus Tissue Implantation (CTTI), Cultured Thymus Tissue Implantation with Parathyroid Transplantation
NCT00579527 phase1 / phase2completednot on this map

Phase I/II Trial of Thymus Transplantation With Immunosuppression, #950

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2005 to 2017Enrolled14ConditionsDiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly, Complete DiGeorge SyndromeArmsCultured Thymus Tissue for Implantation (CTTI), Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation, Blood Draw, Rabbit anti-thymocyte globulin, Cyclosporine
NCT00579709 phase1completednot on this map

Thymus Transplantation With Immunosuppression, #884

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2002 to 2019Enrolled15ConditionsDiGeorge Syndrome, DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete DiGeorge SyndromeArmsThymus Tissue for Transplantation
NCT01220531 nacompletednot on this map

Safety and Efficacy of Thymus Transplantation in Complete DiGeorge Anomaly, IND#9836

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2010 to 2023Enrolled29ConditionsComplete DiGeorge Anomaly, DiGeorge Syndrome, DiGeorge Anomaly, Complete DiGeorge SyndromeArmsCultured Thymus Tissue
NCT02274662 phase4completednot on this mapstarted 2014, after this paper: background citation

Expanded Access Protocol Thymus Transplantation for Immunodeficiency, Hematologic Malignancies, and Autoimmune Disease Related to Poor Thymic Function

TypeinterventionalSponsorSumitomo Pharma Switzerland GmbHRan2014 to 2023Enrolled11ConditionsPoor Thymic Function, Immunodeficiency, Athymia, ImmunoreconstitutionArmsCultured Thymus Tissue, Blood Draw, Rabbit Anti-Thymocyte Globulin and Cyclosporine or Tacrolimus
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Ivan K ChinnDepartment of Pediatrics, Division of Allergy and Immunology, Duke University Medical Center, Durham, NC 27710, USA. chinn001@mc.duke.edu
John A Olson
Michael A Skinner
Elizabeth A McCarthy
Stephanie E Gupton
Dong-Feng Chen
Francisco A Bonilla
Robert L Roberts
Maria G Kanariou
Blythe H Devlin
M Louise Markert
Duke Medical Center · USChildren's Hospital Agia Sophia · GRDuke University · USHarvard University · USThe University of Texas Southwestern Medical Center · USUniversity of California, Los Angeles · US

Funding

THYMIC TRANSPLANTATION IN COMPLETE DIGEORGE SYNDROMER01AI047040 · NIAID · DUKE UNIVERSITY · PI MARKERT, M. LOUISE · 1999 to 2014
$8.0M
RESEARCH TRAINING IN ALLERGY AND CLINICAL IMMUNOLOGYT32AI007062 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David B. Peden, John W. Sleasman · 1985 to 2026
$6.1M
Center for Molecular &Cellular Studies of Ped DiseaseK12HD043494 · NICHD · DUKE UNIVERSITY · PI REED, ANN M. · 2003 to 2017
$5.2M
Molecular Mechanisms of Altered Calcium Sensing in Human Parathyroid DiseaseR01DK088188 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI KOH, JAMES, OLSON, JOHN A. · 2010 to 2014
$1.7M
Parathyroid and Thymus Transplants in DiGeorge SyndromeR21AI060967 · NIAID · DUKE UNIVERSITY · PI MARKERT, MARY LOUISE · 2004 to 2005
$396k
NCRR NIH HHS M03 RR 30NIAID NIH HHS R01 AI 047040NIAID NIH HHS R01 AI047040NIAID NIH HHS R21 AI 060967NIAID NIH HHS R21 AI060967NIAID NIH HHS T32 AI007062NIAID NIH HHS T32 AI 007062-28A2NICHD NIH HHS 2 K12 HD043494 06NICHD NIH HHS K12 HD043494NIDDK NIH HHS R01 DK088188
6 · The paper itself

Abstract

backgroundThe induction of tolerance toward third-party solid organ grafts with allogeneic thymus tissue transplantation has not been previously demonstrated in human subjects.

objectiveInfants with complete DiGeorge anomaly (having neither thymus nor parathyroid function) were studied for conditions and mechanisms required for the development of tolerance to third-party solid organ tissues.

methodsFour infants who met the criteria received parental parathyroid with allogeneic thymus transplantation and were studied.

resultsTwo of 3 survivors showed function of both grafts but subsequently lost parathyroid function. They demonstrated alloreactivity against the parathyroid donor in mixed lymphocyte cultures. For these 2 recipients, parathyroid donor HLA class II alleles were mismatched with the recipient and thymus. MHC class II tetramers confirmed the presence of recipient CD4(+) T cells with specificity toward a mismatched parathyroid donor class II allele. The third survivor has persistent graft function and lacks alloreactivity toward the parathyroid donor. All parathyroid donor class II alleles were shared with either the recipient or the thymus graft, with minor differences between the parathyroid (HLA-DRB1∗1104) and thymus (HLA-DRB1∗1101). Tetramer analyses detected recipient T cells specific for the parathyroid HLA-DRB1∗1104 allele. Alloreactivity toward the parathyroid donor was restored with low doses of IL-2.

conclusionTolerance toward parathyroid grafts in combined parental parathyroid and allogeneic thymus transplantation requires matching of thymus tissue to parathyroid HLA class II alleles to promote negative selection and suppression of recipient T cells that have alloreactivity toward the parathyroid grafts. This matching strategy may be applied toward tolerance induction in future combined thymus and solid organ transplantation efforts.

Indexed as

AdultDiGeorge SyndromeGraft SurvivalHistocompatibility Antigens Class IIHistocompatibility TestingHumansInfantLymphocyte Culture Test, MixedParathyroid GlandsParentsThymus GlandTransplantation, HomologousTransplantation ToleranceTreatment OutcomeHistocompatibility Antigens Class II

Identifiers

PMID20832849
PMCPMC2962450
OpenAlexW2133818820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.